Mahmud R. Huq

Square Hospital Ltd
Dhaka, C, Bangladesh

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Ruptured Cerebral Arteriovenous Malformation Initially Managed As Presumed Eclampsia: A Diagnostic Challenge Following Initial Management in a Resource-Limited Setting.

Ruptured Cerebral Arteriovenous Malformation Initially Managed As Presumed Eclampsia: A Diagnostic Challenge Following Initial Management in a Resource-Limited Setting.

Journal: Cureus
Published: July 27, 2026

Veno-Venous Extracorporeal Membrane Oxygenation as Rescue Therapy for Near-Fatal Asthma: A Case Report.

Veno-Venous Extracorporeal Membrane Oxygenation as Rescue Therapy for Near-Fatal Asthma: A Case Report.

Journal: Cureus
Published: April 28, 2026

Therapeutic plasma exchange in expanded dengue patients having acute liver failure: A case series.

Therapeutic plasma exchange in expanded dengue patients having acute liver failure: A case series.

Journal: Tropical doctor
Published: September 28, 2024

Aerosolized Plus Intravenous Polymyxin B Versus Colistin in the Treatment of Pandrug-Resistant Klebsiella Pneumonia-mediated Ventilator-Associated Pneumonia: A Retrospective Cohort Study in Bangladesh.

Aerosolized Plus Intravenous Polymyxin B Versus Colistin in the Treatment of Pandrug-Resistant Klebsiella Pneumonia-mediated Ventilator-Associated Pneumonia: A Retrospective Cohort Study in Bangladesh.

Journal: Journal of critical care medicine (Universitatea de Medicina si Farmacie din Targu-Mures)
Published: October 10, 2022

Therapeutic safety and efficacy of triple-immunosuppressants versus dual-immunosuppressants in severe-to-critical COVID-19: a prospective cohort study in Bangladesh.

Therapeutic safety and efficacy of triple-immunosuppressants versus dual-immunosuppressants in severe-to-critical COVID-19: a prospective cohort study in Bangladesh.

Journal: Annals of medicine
Published: March 03, 2022

Secukinumab in severe COVID-19 pneumonia: Does it have a clinical impact?

Secukinumab in severe COVID-19 pneumonia: Does it have a clinical impact?

Journal: The Journal of infection
Published: May 12, 2021

Impact of high dose of baricitinib in severe COVID-19 pneumonia: a prospective cohort study in Bangladesh.

Impact of high dose of baricitinib in severe COVID-19 pneumonia: a prospective cohort study in Bangladesh.

Journal: BMC infectious diseases
Published: January 01, 2021

Additional baricitinib loading dose improves clinical outcome in COVID-19.

Additional baricitinib loading dose improves clinical outcome in COVID-19.

Journal: Open medicine (Warsaw, Poland)
Published: August 07, 2020

The Susceptibility of MDR-K. Pneumoniae To Polymyxin B Plus Its Nebulised Form Versus Polymyxin B Alone in Critically Ill South Asian Patients.

The Susceptibility of MDR-K. Pneumoniae To Polymyxin B Plus Its Nebulised Form Versus Polymyxin B Alone in Critically Ill South Asian Patients.

Journal: Journal of critical care medicine (Universitatea de Medicina si Farmacie din Targu-Mures)
Published: July 15, 2020

A young adult with 
post-traumatic breathlessness, unconsciousness and rash.

A young adult with 
post-traumatic breathlessness, unconsciousness and rash.

Journal: Breathe (Sheffield, England)
Published: November 29, 2019

Nipah virus encephalitis: MRI findings.

Nipah virus encephalitis: MRI findings.

Journal: The journal of the Royal College of Physicians of Edinburgh
Published: September 10, 2019

The Use of High Dose Eltrombopag in the Management of Sepsis-Associated Thrombocytopenia in Critically Ill Patients.

The Use of High Dose Eltrombopag in the Management of Sepsis-Associated Thrombocytopenia in Critically Ill Patients.

Journal: Journal of critical care medicine (Universitatea de Medicina si Farmacie din Targu-Mures)
Published: May 15, 2019
Showing 1-12 of 12

Last Updated: 09/26/2026